文献速递慢性肾脏病

应用联合模型分析eGFR与死亡率的关联:冰岛全国性研究结果

Association of eGFR and mortality with use of a joint model: results of a nationwide study in Iceland.
PubMed 文献 · Nephrol Dial Transplant · 2023-01-01

结果显示,各eGFR类别中蛋白尿均与死亡风险增加相关;≤65岁人群eGFR 75-89且无蛋白尿时风险最低,>65岁人群eGFR 60-74且无蛋白尿时风险最低;eGFR>104与死亡率增加相关。

要点

  • 各eGFR类别中,蛋白尿均与死亡风险增加相关。
  • ≤65岁无蛋白尿者eGFR 75-89 mL/min/1.73 m2时死亡风险最低。
  • >65岁无蛋白尿者eGFR 60-74 mL/min/1.73 m2时死亡风险最低。

核心结论

  • 研究结果进一步支持使用年龄适配的eGFR阈值来定义慢性肾脏病。
  • 极高的eGFR与死亡率的关系需要更详细地研究。

研究设计与样本

  • 共纳入218 437名个体,获得2 120 147个肌酐值,其中84 364人(39%)有蛋白尿检测结果。
  • eGFR采用慢性肾脏病流行病学协作组公式计算,并按0-29、30-44、45-59、60-74、75-89、90-104和>104 mL/min/1.73 m2分类。
  • 采用多重插补法处理缺失的尿蛋白数据,并使用联合模型评估全因死亡风险。

主要发现

  • 中位年龄46岁(范围18-106岁),47%为男性。
  • 在所有年龄组中,蛋白尿与所有eGFR类别的死亡风险增加相关。
  • 在≤65岁人群中,无蛋白尿且eGFR为75-89 mL/min/1.73 m2时死亡风险最低。
  • 在>65岁人群中,无蛋白尿且eGFR为60-74 mL/min/1.73 m2时死亡风险最低;该年龄组中无蛋白尿且eGFR为45-59 mL/min/1.73 m2与死亡风险增加无关。
  • eGFR>104 mL/min/1.73 m2与死亡率增加相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Prior studies on the association of estimated glomerular filtration rate (eGFR) and mortality have failed to include methods to account for repeated eGFR determinations. The aim of this study was to estimate the association between eGFR and mortality in the general population in Iceland employing a joint model. METHODS: We obtained all serum creatinine and urine protein measurements from all clinical laboratories in Iceland in the years 2008-16. Clinical data were obtained from nationwide electronic medical records. eGFR was calculated using the Chronic Kidney Disease Epidemiology Collaboration equation and categorized as follows: 0-29, 30-44, 45-59, 60-74, 75-89, 90-104 and >104 mL/min/1.73 m2. A multiple imputation method was used to account for missing urine protein data. A joint model was used to assess risk of all-cause mortality. RESULTS: We obtained 2 120 147 creatinine values for 218 437 individuals, of whom 84 364 (39%) had proteinuria measurements available. Median age was 46 (range 18-106) years and 47% were men. Proteinuria associated with increased risk of death for all eGFR categories in persons of all ages. In persons ≤65 years, the lowest risk was observed for eGFR of 75-89 mL/min/1.73 m2 without proteinuria. For persons aged >65 years, the lowest risk was observed for eGFR of 60-74 mL/min/1.73 m2 without proteinuria. eGFR of 45-59 mL/min/1.73 m2 without proteinuria did not associate with increased mortality risk in this age group. eGFR >104 mL/min/1.73 m2 associated with increased mortality. CONCLUSIONS: These results lend further support to the use of age-adapted eGFR thresholds for defining chronic kidney disease. Very high eGFR needs to be studied in more detail with regard to mortality.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Jonsson AJ, Lund SH, Eriksen BO, et al. Association of eGFR and mortality with use of a joint model: results of a nationwide study in Iceland. Nephrol Dial Transplant. 2023. PMID: 36758988. doi:10.1093/ndt/gfad033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。